Improving Research and Treatment in Epilepsy, Stroke and Schizophrenia

UPEI’s Dr R. Andrew Tasker is a neuropharmacologist with a passion to improve both research and treatment around key neurological disorders such as epilepsy, stroke and schizophrenia. Synapse worked with Dr Tasker and contract research organization, CNS|CRO Preclinical Neurological Disease Services to facilitate a license agreement for three innovative new animal models that can greatly enhance research of new drugs in these key areas.

Synapse was also able to help with the patenting of the epilepsy animal model in the United States and Canada. The rodent models can be found on the CNS|CRO website.